Lithium in treatment and prevention of affective disorder. A VA-NIMH collaborative study.
Pokorny
A D
AD
Psychiatry Service, VA Hospital, Houston, Texas, USA.
Prien
R F
RF
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D002746:Chlorpromazine / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D018020:Lithium Compounds / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D008297:Male; D019964:Mood Disorders / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control*; D011618:Psychotic Disorders / Q000188:drug therapy; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D007099:Imipramine; D002746:Chlorpromazine